Proud to share that QP-Prostate has been selected for a major @NHSEngland-backed rollout across 7 hospitals to improve early #ProstateCancer detection. 3,000+ patients to be assessed over 2 years. Enabled by @sbrihealthcare. 🔗 #AIinHealthcare #NHS

▶️If you were unable to attend live our #webinar 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2, endorsed by @SERAM_RX, you can watch the full session here: #Radiology #HealthcareInnovation #AI.

We are proud to announce the launch of AI-QUAL™, an innovative new feature in our flagship QP-Prostate platform, designed to automate prostate MR image quality assessment using PI-QUAL v2 guidelines. 👉 #MedicalImaging #AIinHealthcare #ProstateCancer

The 13th @EsurOffice prostate MRI course is being held today in Cambridge. We are grateful that our team can hear directly from radiologists and oncologists to help us better understand their challenges, refine our solutions and make a meaningful contribution to #ProstateCancer.

Global events like #ASCO2025 reveal major strides in #oncology—but can public healthcare systems keep up with the promise of precision medicine? Dive into the full interview:

Today the last Consortium Meeting of the #ProCanAid project, coordinated by Quibim and with the collaboration of @unizar and @IISLaFe, was held. This project is now complete, but its achievements are sure to improve the future of precision medicine. Thank you to all partners!

We're ready for #ASCO2025! . With four accepted abstracts and the newest QP-Insights features at our booth, Quibim's presence at @ASCO underscores our strong commitment to transform #healthcare. 📩 Book a demo here:

That’s a wrap for #AUA2025! From insightful demos to engaging conversations with leading experts, we’re thrilled with the impact QP-Prostate CAD is making. Explore QP-Prostate® CAD 👉 📅 Book a demo: #AIinHealth #Urology

🇳🇱@aalberich will join the stage at @ECIOcongress in Rotterdam to discuss: 𝘌𝘵𝘩𝘪𝘤𝘢𝘭, 𝘗𝘳𝘢𝘤𝘵𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘊𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘷𝘦 𝘜𝘴𝘦𝘴 𝘰𝘧 𝘈𝘐 𝘪𝘯 𝘐𝘯𝘵𝘦𝘳𝘷𝘦𝘯𝘵𝘪𝘰𝘯𝘢𝘭 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺. Don't miss it! . #AIinHealthcare #EthicalAI #ECIO2025

With renewed leadership, FDA clearance for QP-Prostate CAD and a $50M Series A, Quibim enters a new era of growth and strategic expansion that will certainly scale and shape the future of precision healthcare. Introducing our new Board of Directors:

CADt, CADe, CADx – What’s the Difference? . ⚡ 𝐂𝐀𝐃𝐭: Identifies potentially urgent cases without making a diagnosis. 🩺 𝐂𝐀𝐃𝐞: Flags suspicious regions on medical images to assist as a second reader. 🔬 𝐂𝐀𝐃𝐱: Analyzes and characterizes lesions to support diagnostic

🏆 We’re thrilled to share that Quibim has secured 3rd place in the 50-100 employees category of Spain’s #BestWorkplaces25!. This recognition by @GPTW_Spain reflects our commitment to a people-first culture and workplace well-being. A huge thank you to our incredible team—let’s

Ahead of #ECR2025, we had the privilege of speaking with Professor Shonit Punwani—an expert in MRI technology and #prostatecancer imaging. As a @ucl Professor, @uclh Consultant Radiologist & Quibim Medical Advisor, he shared key insights on groundbreaking advances shaping

🚀 We are at the 40th Annual Congress of the European Association of Urology (EAU) in Madrid! . Find us at booth A73, where we will be showcasing the latest advances in QP-Prostate CAD, our AI-based platform for prostate segmentation and lesion detection. @Uroweb. #EAU2025

🌍 We're in Crete for the final @ProCAncer_I consortium meeting!. It's been an amazing journey, and we are very proud of our contributions to the project, leading key areas such as:.✅ Advanced annotation tool for prostate segmentation.✅ Model drift detection in production.✅

📢 Have you booked your place? Today is our webinar in collaboration with @SEFM_redes on Medical Imaging, Radiomics, and its Oncological applications. Details 👇🏻. 📅 March 11 | 17:00 (CET). 🎙 Speaker: Carmen Prieto de la Lastra. 🎤 Moderator: Diego Garcia Pinto. Secure your

Prostate cancer is the most common cancer among men in the UK, yet there’s still no national screening program. Early detection saves lives, and that’s why we’re proud to support @PCR_News in the #ProactiveForYourProstate initiative. Will you join us in making prostate cancer